News & Events

Quantori Named a Major Contender in Everest Group’s Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026

According to Everest Group, pharmaceutical companies are under growing pressure to improve R&D productivity. However, fragmented data and strict requirements for validation and oversight continue to limit the adoption of AI at scale. As a result, buyers are increasingly looking for providers that pair scientific and functional expertise with data, AI, and platform capabilities, the report finds.

Quantori at BioTechX Europe 2026

Advancing Drug Discovery with AI

Quantori Connect 4

Moderated by Alexander Lukyanov, Vice President, AI, Life Science R&D at Quantori, the roundtable featured three panelists from Takeda, Knowledge3, and Harvard T.H. Chan School of Public Health

Quantori MLConfGen Wins “Machine Learning Innovation Award” in 2026 AI Breakthrough Awards Program

Ninth annual program honors the AI innovators shaping the next era of global innovation.

Bio-IT World Presentation 2026: Key Highlights

Lowering the Barriers to Scientific Innovation with Quantori’s Q-Suite Accelerators

Quantori and Knowledge3 Announce Co-Marketing Partnership to Advance Knowledge-Driven AI in Life Sciences

Together, Quantori and Knowledge3 aim to help organizations move beyond fragmented data environments and siloed AI initiatives.